title: Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
abstract: Antithrombin is a key regulator of coagulation and prime target of heparins, clinically used anticoagulants. Heparins induce a two-step conformational activation of antithrombin, a process that has remained challenging to target with molecules devoid of the antithrombin-binding pentasaccharide DEFGH. Computational screening of a focused library led to the design of two tetra-sulfated N-arylacyl tetrahydroisoquinoline variants as potential nonsaccharide activators of antithrombin. A high yielding synthetic scheme based on Horner-Wadsworth-Emmons or Pictet-Spengler reactions was developed to facilitate the functionalization of the tetrahydoisoquinoline ring, which upon further amidation, deprotection, and sulfation gave the targeted nonsaccharide activators. Spectrofluorometric measurement of affinity displayed antithrombin binding affinities in the low to high micromolar range at pH 6.0, I 0.05, 25 °C. Measurement of second-order rate constants of antithrombin inhibition of factor Xa in the presence and absence of the designed activators showed antithrombin activation in the range of 8-80-fold in the pH 6.0 buffer. This work puts forward 20c, a novel tetra-sulfated N-arylacyl tetrahydroisoquinoline-based molecule, that activates AT only 3.8-fold less than that achieved with DEFGH, suggesting a strong possibility of rationally designing sulfated organic molecules as clinically relevant AT activators.
authors.affiliation: Department of Medicinal Chemistry and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
authors.forename: Rami A
authors.initials: RA
authors.lastname: Al-Horani
authors.forename: Aiye
authors.initials: A
authors.lastname: Liang
authors.forename: Umesh R
authors.initials: UR
authors.lastname: Desai
mesh_terms: D000991:Antithrombins / Q000819:agonists*; D001665:Binding Sites; D015195:Drug Design; D065427:Factor Xa Inhibitors; D006801:Humans; D006841:Hydrocarbons, Aromatic / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D008958:Models, Molecular; D015394:Molecular Structure; D011485:Protein Binding; D011487:Protein Conformation; D013329:Structure-Activity Relationship; D013463:Sulfuric Acid Esters / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D044005:Tetrahydroisoquinolines / Q000737:chemistry
chemical_list: D000991:Antithrombins; D065427:Factor Xa Inhibitors; D006841:Hydrocarbons, Aromatic; D013463:Sulfuric Acid Esters; D044005:Tetrahydroisoquinolines